Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferons and autoimmunity.

A Schattner1

  • 1Department of Virology, Weizmann Institute of Science, Rehovot, Israel.

The American Journal of the Medical Sciences
|June 1, 1988
PubMed
Summary
This summary is machine-generated.

Interferon (IFN) can accelerate autoimmune disease in mice and humans. Aberrant expression of MHC class II antigens, induced by IFN-gamma, plays a key role in autoimmune disease development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splenic spread and hepatic encephalopathy in metastatic malignant melanoma.

QJM : monthly journal of the Association of Physicians·2024
Same author

Documenting the patient's visit in the EHR-searching for the holy grail.

QJM : monthly journal of the Association of Physicians·2024
Same author

Sclerosing mesenteritis.

QJM : monthly journal of the Association of Physicians·2023
Same author

Staphylococcus aureus bacteraemia presenting as sternoclavicular arthritis.

QJM : monthly journal of the Association of Physicians·2023
Same author

Euthyroid Graves' ophthalmopathy.

QJM : monthly journal of the Association of Physicians·2023
Same author

Severe CNS relapse of partially treated Listeria: hydrocephalus, brain oedema and coma.

QJM : monthly journal of the Association of Physicians·2023
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Area of Science:

  • Immunology
  • Virology
  • Genetics

Background:

  • Autoimmunity can be accelerated in genetically susceptible murine models.
  • Interferon (IFN) or IFN-inducers can trigger autoimmune disease.
  • IFN plays a role in mediating or enhancing autoimmune disease manifestations and immunological aberrations.

Purpose of the Study:

  • To investigate the role of interferon in the induction and exacerbation of autoimmune diseases.
  • To explore the significance of circulating IFN levels and specific IFN types in autoimmune patients.
  • To understand the mechanism by which IFN-gamma induces MHC class II antigen expression and its implication in autoimmunity.

Main Methods:

  • Studies in genetically prone murine models.
  • Treatment of normal mice with interferon or interferon-inducers.

Related Experiment Videos

  • Clinical observation of human cases with IFN-induced autoimmune disease.
  • Analysis of circulating IFN levels and types in patients.
  • Investigation of IFN-gamma's effect on MHC class II antigen expression.
  • Main Results:

    • Interferon (IFN) can accelerate or induce autoimmunity in mice.
    • Autoimmune disease cases linked to IFN treatment have been observed in humans.
    • High levels of circulating IFN, particularly acid-labile IFN-alpha (often associated with viral infections), are found in many patients.
    • IFN-gamma induces MHC class II antigens on cells that are normally negative for these markers.
    • Aberrant HLA-DR expression on nonlymphoid cells is an early indicator in various autoimmune conditions.

    Conclusions:

    • Interferon is implicated in the pathogenesis of autoimmune diseases.
    • The presence of specific IFN types, like acid-labile IFN-alpha, may suggest an infectious etiology for autoimmunity.
    • IFN-gamma-induced MHC class II expression on nonlymphoid cells is a critical factor in initiating autoimmune responses.